Pharma Blog Watch

Elections and the FDA (Eye on FDA)
In his blog, Mark Senak continues his discussion of how the upcoming elections will affect the FDA, today writing about the House elections. On the House side of things "it is more likely that a switch of leadership will occur and if it does, you can count on a spate of reform proposals and a good number of hearings and investigations."

"That means that the agency should be preparing a public affairs plan that takes this scenario into account and incorporates it into its overall proactive communications planning. Unfortunately, to date, there is little evidence that this sort of planning is something that is part of the culture given a track record that has been entirely reactive, and ineffective at that," he writes.